ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Dosage"

  • 2017 American Transplant Congress

    A Pilot Trial of Genotype-Guided Dosing versus Standard Clinical Dosing in Pediatric Solid Organ Transplants.

    S. Min, T. Daljevic, M. Lafreniere-Roula, C. Manlhiot, N. Nalli, H. Grasemann, S. Schwartz, B. Kamath, V. Ng, R. Parekh, S. Mital.

    The Hospital for Sick Children, Toronto, ON, Canada

    Purpose: Tacrolimus pharmacokinetics are influenced by age and variation in the CYP3A5 gene with CYP3A5 expressors (AA/AG) being fast metabolizers. The purpose of this trial…
  • 2017 American Transplant Congress

    Prevalence of CYP3A Genomic Variances and Impact on Tacrolimus Dosing Requirements in Kidney Transplant Recipients in Eastern North Carolina.

    T. Asempa,1 S. Hudson,2 L. Rebellato,2 A. Maldonado.1

    1Vidant Medical Center, Greenville, NC; 2East Carolina University, Greenville, NC

    BACKGROUND: African American (AA) patients are substantially more likely to express CYP3A5. Presence of CYP3A5 polymorphisms is an important pharmacotherapeutic consideration due to the extensive…
  • 2017 American Transplant Congress

    Tacrolimus Pharmacogenomics: Association of Genetic Variants with Clinical Factors Including Tacrolimus Requirement, Clearance, Intraindividual Variability, and Coefficient Variation.

    S.-Y. Kim,1 J. Oh,2 S. Yun,2 I.-J. Jang,2 S.-I. Min,1 W. Cho,1 S. Cho,1 S. Ahn,1 S.-K. Min,1 J. Ha.1

    1Surgery, Seoul National University College of Medicine, Seoul, Korea; 2Clinical Pharmacology, Seoul National University College of Medicine, Seoul, Korea

    Background: Tacrolimus, which plays a backbone in immunosuppressive therapy, has a different effect in absorption according to intraindividual and interindividual variability, and it is a…
  • 2017 American Transplant Congress

    Is Once-Daily Extended-Release Tacrolimus Better Than Twice-Daily Standard-Release Tacrolimus? A Meta-Analysis of Randomized Controlled Trials.

    G. Gu, H. Hang, Q. Xia.

    Department of Hepatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

    Tacrolimus is one of the major immunosuppressants commonly used in transplant recipients. Extended-release tacrolimus is expected to have immunosuppressant effects equivalent to standard-release tacrolimus while…
  • 2017 American Transplant Congress

    Association with Tacrolimus Intraindividual Variability, Acute Microinflammation Based on 1 Year-Transplanted Kidney Biopsy After Transplantation, and Biopsy-Proven Acute Rejection.

    S.-Y. Kim, S.-I. Min, W. Cho, S. Cho, M.-J. Cho, S. Ahn, S.-K. Min, J. Ha.

    Surgery, Seoul National University College of Medicine, Seoul, Korea

    Background: The purpose of this study was to investigate relationship between tacrolimus intraindividual variability (IIV), acute microinflammation (AMI) based on 1 year-transplanted kidney biopsy, and…
  • 2017 American Transplant Congress

    Impact of Antihypertensive (AHT) Choice and Advagraf® Dose on Interstitial Fibrosis/Tubular Atrophy (IF/TA) and IF/TA Progression in Renal Allografts 24 Months Post-Transplantation (Tx).

    S. Cockfield,1 D. Rush,2 S. Wilson,3 J. Howell,4 FKC-014 Study Group.

    1University of Alberta Hospital, Edmonton, AB, Canada; 2Health Sciences Centre, Winnipeg, MB, Canada; 3Astellas Pharma Global Development, Northbrook, IL; 4Astellas Pharma Global Development, Markham, ON, Canada

    IF/TA may be delayed using ACEi- or ARB-type AHTs, which target the renin-angiotensin system (RAS), as well as by optimizing tacrolimus (TAC) exposure. The effect…
  • 2017 American Transplant Congress

    Higher Tacrolimus Blood Levels Predict Better Graft Survival in Kidney Recipients with De Novo DSA.

    M.-A. Béland,1 R. Noël,1 I. Côté,1 I. Lapointe,1 E. Wagner,2 J. Riopel,3 E. Latulippe,3 O. Désy,1 S. Béland,1 I. Houde,1 S. De Serres.1

    1Renal Division, CHU de Quebec, Laval University, Quebec City, QC, Canada; 2Immunology and Histocompatibility, CHU de Quebec, Laval University, Quebec City, QC, Canada; 3Pathology, CHU de Quebec, Laval University, Quebec City, QC, Canada

    Background: De novo anti-HLA donor specific antibodies (dnDSA) are associated with poorer outcomes in kidney transplant recipients. Nonetheless, their monitoring post transplant is not widespread,…
  • 2016 American Transplant Congress

    Blockade of HLA Antibody-Triggered Classical Complement Activation by High-Affinity Humanized Monoclonal Anti-C1s Antibody TNT009 – Results of a First-in-Human Phase 1 Trial.

    J. Mühbacher,1 B. Jilma,2 M. Wahrmann,3 L. Marinova,3 F. Eskandary,3 J. Gilbert,4 S. Panicker,4 G. Böhmig.3

    1Department of Surgery, Medical University of Vienna, Vienna, Austria; 2Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria; 3Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria; 4True North Therapeutics, Inc., South San Francisco, CA.

    Study purpose: Classical complement may play a key role in ABMR. A promising therapeutic approach could be complement inhibition at the level of key component…
  • 2016 American Transplant Congress

    Establishing the Relationship Between Receptor Occupancy, Serum Exposure and Pathway Inhibition by the Blocking, Non-Depleting Anti-CD40 Antibody CFZ533 to Inform Dose Selection in Clinical Transplantation.

    P. Espie, J. Munz, T. Flandre, B. Haraldsson, P. Ulrich, J. Rush.

    Novartis Institutes for Biomedical Research, Basel, Switzerland.

    Background. CD40-CD154 pathway blockade significantly prolongs renal allograft survival in non-human primates (NHPs), and trials of the novel blocking, non-depleting anti-CD40 monoclonal antibody (mAb) CFZ533…
  • 2016 American Transplant Congress

    Advantages of Computerized Dosing Strategy in Tacrolimus Treatment of Renal Transplant Patients.

    S.-Y. Kim,1 S. Cho,1 M.-J. Cho,1 C. Lee,1 A. Han,1 C. Choi,1 S. Ahn,1 S.-I. Min,1 S.-K. Min,1 M. Park,2 I. Jung,3 S. Kim,4 J. Ha.1,2

    1Department of Surgery, Seoul National University Hospital, Seoul, Korea; 2Korea Organ Donation Agency, Seoul, Korea; 3Department of surgery, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea; 4Department of Surgery, Myoungji Hospital, Goyang-si, Korea.

    Purpose: Tacrolimus (Tac) is widely used in immunosuppression for kidney transplant (KT) patients. Despite this, it is still difficult for expert physicians to achieve and…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences